Pragmatic compulsory licensing policy is needed to enable India to look after health of its people as it cannot afford monopoly in healthcare with the challenges it faces, Cipla's Y K Hamied said. DNA, 5 days ago
Drug firm Cipla has appointed Peter Lankau as an independent director on its board with effect from January 10. Lankau is currently a principal of Lankau Consulting LLC. He serves on the Board of Directors of ANI Pharmaceuticals Inc and Phosphagenics Ltd and ...Business Standard, 1 month ago
on your WebpageAdd Widget >Get your members hooked!